Literature DB >> 6498343

Autoimmune hemolytic anemia by coexisting anti-I and anti-Fl cold agglutinins.

A L König, H Kather, D Roelcke.   

Abstract

In association with atypical pneumonia, a patient developed acute severe autoimmune hemolytic anemia. Hemoglobin temporarily was only 7.0 g/100 ml, so that the patient needed red blood cell (RBC) transfusion. Hemolysis was found to be caused by high titer cold agglutinins (CA), which occurred transiently during the acute period of the disease. CA of two different specificities, anti-I and anti-Fl, were demonstrated in the patient's serum. Antibodies of the two specificities were clearly separated by absorption/elution experiments using neuraminidase (RDE)-treated RBC. They were distinguished by serologic means: Both anti-I and anti-Fl react more strongly with adult RBC than with newborn and i adult RBC; in contrast to anti-I, anti-Fl does not agglutinate RDE-treated cells. Inhibition experiments showed that I-active substances prepared from papainized RBC exhibited both I and Fl antigenic activity. By RDE-treatment of I-active substances, Fl-activity was markedly reduced, while I-activity was increased.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498343     DOI: 10.1007/bf00319883

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  19 in total

1.  Anti-Pr3: serological and immunochemical identification of a new anti-Pr subspecificity.

Authors:  D Roelcke; W Ebert; H P Geisen
Journal:  Vox Sang       Date:  1976       Impact factor: 2.144

2.  Specificity of IgA cold agglutinins: anti-Pr 1 .

Authors:  D Roelcke
Journal:  Eur J Immunol       Date:  1973-04       Impact factor: 5.532

3.  A further cold agglutinin, F1, recognizing a N-acetylneuraminic acid-determined antigen.

Authors:  D Roelcke
Journal:  Vox Sang       Date:  1981       Impact factor: 2.144

Review 4.  Blood group ABH and Ii antigens of human erythrocytes: chemistry, polymorphism, and their developmental change.

Authors:  S Hakomori
Journal:  Semin Hematol       Date:  1981-01       Impact factor: 3.851

5.  Serological identification of the new cold agglutinin specificity anti-Gd.

Authors:  D Roelcke; W Riesen; H P Geisen; W Ebert
Journal:  Vox Sang       Date:  1977       Impact factor: 2.144

6.  I-, MN- and Pr1/Pr2-activity of human erythrocyte glycoprotein fractions obtained by ficin treatment.

Authors:  D Roelcke; W Ebert; J Metz; H Weicker
Journal:  Vox Sang       Date:  1971-10       Impact factor: 2.144

7.  A new human monoclonal cold agglutinin Sa recognizing terminal N-acetylneuraminyl groups on the cell surface.

Authors:  D Roelcke; W Pruzanski; W Ebert; W Römer; E Fischer; V Lenhard; E Rauterberg
Journal:  Blood       Date:  1980-04       Impact factor: 22.113

8.  The Lud cold agglutinin: a further antibody recognizing N-acetylneuraminic acid-determined antigens not fully expressed at birth.

Authors:  D Roelcke
Journal:  Vox Sang       Date:  1981 Nov-Dec       Impact factor: 2.144

9.  The reactivities of human erythrocyte autoantibodies anti-Pr2, anti-Gd, Fl and Sa with gangliosides in a chromatogram binding assay.

Authors:  K Uemura; D Roelcke; Y Nagai; T Feizi
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

10.  Cold agglutinin Vo. An IgM lambda monoclonal human antibody recognizing a sialic acid determined antigen fully expressed on newborn erythrocytes.

Authors:  D Roelcke; H Kreft; A M Pfister
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

View more
  1 in total

1.  Clearance of pathological antibodies using biomimetic nanoparticles.

Authors:  Jonathan A Copp; Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Weiwei Gao; Kang Zhang; Liangfang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.